The global Diaphragm Pacing Therapy System market size is expected to reach USD 21.5 million by 2030 and is expected to expand at a CAGR of 10.6% from 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38463
Growth Factors
Some of the factors contributing to the market growth are the upsurge in the prevalence of breathing disorders including sleep apnea, the rise in spinal cord injuries, and amyotrophic lateral sclerosis.
The growing prevalence of disorders including sleep apnea, amyotrophic lateral sclerosis, and spinal cord injuries is expected to support the growth of the market. The diaphragm pacemaker is more accurate, comfortable compared to the mechanical ventilators and reduces the risk of upper airway infections such as ventilator-associated pneumonia. In addition, the favorable regulatory policies and approvals are fueling the adoption of the diaphragm pacing therapy systems.
Report Highlights
In 2020, the external diaphragm pacemaker segment dominated the market and accounted for the largest revenue share of 67.8%. Based on the product, the market for the diaphragm pacing therapy system is segmented into external diaphragm pacemaker and diaphragm pacemaker.
The spinal cord injury segment dominated the market and accounted for the largest revenue share of 55.5% in 2020 owing to the growing number of spinal cord injuries annually worldwide. According to the National Spinal Cord Injury Statistical Center, around 17,000 new spinal cord injury cases are reported every year in the U.S.
North America dominated the diaphragm pacing therapy system market and accounted for the largest revenue share of 69.7% in 2020. The market is expected to grow well in the region over the forecast period owing to the prevalence of breathing disorders including sleep apnea, amyotrophic lateral sclerosis, and spinal cord injuries in the region. Furthermore, the improving healthcare expenditure and the growing disposable incomes of patients are expected to contribute to market growth in the region.
Key Players
- Lungpacer Medical Inc.
- Avery Biomedical Devices, Inc.
- Synapse Biomedical
- Atrotech
| Report Coverage | Details |
| Market Size | US$ 21.5 million by 2030 |
| Growth Rate | CAGR of 10.6% From 2021 to 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, Application |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Lungpacer Medical Inc.; Avery Biomedical Devices, Inc.; Synapse Biomedical; Atrotech |
Market Segmentation
- Product
- External Diaphragm Pacemaker
- Diaphragm Pacemaker
- Application
- Spinal Cord Injury
- Amyotrophic Lateral Sclerosis
- Others
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
- North America
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38463
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Diaphragm Pacing Therapy System Market, By Product
7.1. Diaphragm Pacing Therapy System Market, by Product, 2021-2030
7.1.1. External Diaphragm Pacemaker
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Diaphragm Pacemaker
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Diaphragm Pacing Therapy System Market, By Application
8.1. Diaphragm Pacing Therapy System Market, by Application, 2021-2030
8.1.1. Spinal Cord Injury
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Amyotrophic Lateral Sclerosis
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Diaphragm Pacing Therapy System Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2017-2030)
9.1.2. Market Revenue and Forecast, by Application (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.1.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.1.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
9.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
9.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.4.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
9.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2017-2030)
9.5.2. Market Revenue and Forecast, by Application (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2017-2030)
9.5.3.2. Market Revenue and Forecast, by Application (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
9.5.4.2. Market Revenue and Forecast, by Application (2017-2030)
Chapter 10. Company Profiles
10.1. Lungpacer Medical Inc.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Avery Biomedical Devices, Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Synapse Biomedical
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Atrotech
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38463
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
